Executive Director, April 2024 to PresentSenior Director, September 2021 to March 2024• Build Pricing & Contracting strategies for currently marketed and future products across Provider & Payer channels• Partner with Market Access & Account Teams to execute Provider and Payer strategies, address account-specific contracting opportunities, and explore expanded market opportunities • Collaborate with Market Access & Strategic Accounts leadership to monitor market conditions, changes in laws and regulations as well as educate internal & external personnel on such changes. • Collaborating with Finance, Legal, Government Pricing, Compliance and other departments to establish consistent business rules and “playbooks” focused on data-supported pricing and contracting strategies.• Strategize, partner and strengthen work internal stakeholders (Contract Operations, Market Access, Trade Development, Finance, Analytics, Sales, Market Access, Compliance, and Legal) to assess and influence contract and discount design to ensure operational feasibility of such arrangements• Drive the development of innovative solutions and processes including the development of new approaches for projects, applications and department service offerings• Develop, coach, lead, mentor, and retain a dynamic, high performing learning team

Led the development of global pricing strategies for Alpha and Hematology Portfolio working cross functionally with global, regional and country teams including Pricing, Market Access, HEOR, Brand, Medical Affairs and Commercial organizations. Conducted oncology pricing research in collaboration with key markets and regions. Worked closely with regions & countries to support their pricing and reimbursement needs. Provide pricing input to global & regional brand planning process and portfolio reviews as a member of both Global Product and Global Brand Teams . Enhanced information exchange and best practice sharing across regions. Drove adoption of global & regional pricing approvals, policies, tools and guidance.

Director, April 2018 to December 2018 Associate Director, January 2017 to March 2018Developed, executed and monitored U.S. Pricing & Contracting strategies that impacted patient and physician access to Ipsen’s Product Portfolio. Created proposals and negotiated agreements across multiple channels, including Physician Neurology & Oncology Clinic GPOs, Hospitals, Commercial Payers, 340B Entities, Veteran’s Administration (VA), Medicaid, and Medicare. Collaborated with Finance to forecast volume & discounts and assess GTN impact and profitability by channel throughout the various financial modeling, forecasting and budgeting cycles. Partnered with internal stakeholders including Account Management, Product Brand Teams, Field Sales, Finance, Legal, and Compliance.

Led strategic planning and execution for U.S. Pricing & Contracting programs in support of Eisai’s Oncology and Neurology brands. Developed and presented proposals for contracting & pricing strategies, rebates, reimbursement and list price actions to Eisai U.S. Price Committee. Worked closely with Account Management and Brand teams on formulary reviews, market share analysis, and competitive intelligence using Fingertip Formulary, Analysource, IQVIA, and customer-supplied data. Supported Eisai Trade Relations sales operations for wholesaler & distributor inventory management, ValueCentric reporting, and ownership of U.S. Price List.

Partnered with Managed Care Organizations (MCO), Pharmacy Benefit Managers (PBM), Long Term Care providers (LTC), and Group Purchasing Organizations (GPO) to help ensure Warner Chilcott prescription drug products were covered on formularies for patients. Developed customer offers utilizing financial models that include: return on investment, gross to net, deal vs. no deal scenario and impact to government price.

Negotiated global master supply contracts, statements of work, and confidentiality agreements for Active Pharmaceutical Ingredient (API) suppliers and finished dosage contract manufacturing organizations (CMOs) including contract terms, pricing, price, and payment schedules to ensure quality, cost, and continuity of supply.

Managed relationship with 25 Integrated Delivery Network, Consolidated Service Center, Regional GPOs and hospital customers to meet business and customer goals. Worked closely with the Contract Director and J&J Operating Company representatives to develop proposals and execute contracts for the majority of the J&J Medical Device and Diagnostics product portfolio.

Oversaw development, execution and administration of rebate contracts for twenty one Managed Care and Managed Markets customers across four books of business (Commercial, Medicare Part D, Managed Medicaid, and Pharmaceutical Benefit Managers) representing approximately twelve products from both the small and large molecule J&J pharmaceutical portfolio.

Managed four cross functional project teams to identify, assess, prioritize and manage process improvement and reengineering opportunities throughout the contract management process for J & J Operating Companies representing Pharmaceutical and Medical Device & Diagnosic markets. Led a process improvement charter involving six J&J Operating Companies to improve contract strategy evaluation and implementation process.

Identified global privacy laws, rules and regulations (e.g. HIPAA, EU Directive on Data Protection, and other privacy and data security requirements) facing BD’s five global business regions and designed compliant policies, procedures and solutions. Designed, coordinated and delivered an effective and localized privacy training program for BD associates worldwide.

Administered the contract management relationship, including five separate Medical Surgical awards, for Novation LLC (now Vizient Inc.) one of BD’s largest contract customers. Directed conversion of contract-related data files (customer, product, price, roster, eligibility) from numerous legacy systems to one SAP instance improve BD’s operational efficiency and competitiveness.

Managed monthly volunteer projects for individuals, civic groups and corporations that consisted of scheduling, identifying, tracking and evaluating approximately 50 monthly projects, 150 volunteers and 300 volunteer hours.